Norrie Russell has been appointed president of Gene Logic, an Ocimum Biosolutions company, Ocimum announced this week.
Prior to joining Gene Logic, Russell held leadership roles with NovaRx, Invitrogen, Aviva Biosciences, and Lynx Therapeutics. He also worked at AstraZeneca, where he was global head of biological science and technology.
Russell holds a PhD in physiology from Glasgow University in Scotland.
San Francisco-based molecular diagnostics startup MLC Dx recently disclosed several company executives in a filing with the US Securities and Exchange Commission.
Thomas Willis is the company's president and CEO. Prior to that, he worked at Affymetrix, following the firm’s acquisition of ParAllele BioScience, a company he co-founded and where he served as CEO and later as chief scientific officer.
Malek Faham is the firm's CSO. Previously, he was vice president of oncology technology research at Affymetrix, and before that, director of research at ParAllele, which he also co-founded.